BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 14994974)

  • 1. Voriconazole for serious fungal infections.
    Gothard P; Rogers TR
    Int J Clin Pract; 2004 Jan; 58(1):74-80. PubMed ID: 14994974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole: a new triazole antifungal.
    Sabo JA; Abdel-Rahman SM
    Ann Pharmacother; 2000 Sep; 34(9):1032-43. PubMed ID: 10981251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole : a review of its use in the management of invasive fungal infections.
    Scott LJ; Simpson D
    Drugs; 2007; 67(2):269-98. PubMed ID: 17284090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole: therapeutic review of a new azole antifungal.
    Herbrecht R
    Expert Rev Anti Infect Ther; 2004 Aug; 2(4):485-97. PubMed ID: 15482215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole: a new triazole antifungal agent.
    Pearson MM; Rogers PD; Cleary JD; Chapman SW
    Ann Pharmacother; 2003 Mar; 37(3):420-32. PubMed ID: 12639175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
    Jørgensen KJ; Gøtzsche PC; Dalbøge CS; Johansen HK
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD004707. PubMed ID: 24563222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
    Cecil JA; Wenzel RP
    Expert Rev Hematol; 2009 Jun; 2(3):237-54. PubMed ID: 21082966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Voriconazole: a new weapon against invasive fungal infections].
    Aoun M
    Rev Med Brux; 2004 Jun; 25(3):166-71. PubMed ID: 15291449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voriconazole: a new triazole antifungal agent.
    Johnson LB; Kauffman CA
    Clin Infect Dis; 2003 Mar; 36(5):630-7. PubMed ID: 12594645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voriconazole -- better chances for patients with invasive mycoses.
    Ghannoum MA; Kuhn DM
    Eur J Med Res; 2002 May; 7(5):242-56. PubMed ID: 12069915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole versus amphotericin B in cancer patients with neutropenia.
    Jørgensen KJ; Gøtzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole.
    Jeu L; Piacenti FJ; Lyakhovetskiy AG; Fung HB
    Clin Ther; 2003 May; 25(5):1321-81. PubMed ID: 12867215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].
    Quindós G; Carrillo-Muñoz AJ; Eraso E; Cantón E; Pemán J
    Rev Iberoam Micol; 2007 Sep; 24(3):198-208. PubMed ID: 17874856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the safety and efficacy of voriconazole.
    Hoffman HL; Rathbun RC
    Expert Opin Investig Drugs; 2002 Mar; 11(3):409-29. PubMed ID: 11866669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole: review of a broad spectrum triazole antifungal agent.
    Kofla G; Ruhnke M
    Expert Opin Pharmacother; 2005 Jun; 6(7):1215-29. PubMed ID: 15957974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of voriconazole in the treatment of emerging mycoses].
    Pastor FJ; Guarro J
    Rev Iberoam Micol; 2007 Sep; 24(3):228-32. PubMed ID: 17874861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
    Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
    J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.